Jansen to retire from Pfizer

Kathrin Jansen, SVP and head of vaccine R&D at Pfizer Inc. (NYSE:PFE), will retire from the company later this year. Jansen led the development of the Comirnaty vaccine with  BioNTech SE (NASDAQ:BNTX)  — the crowning achievement of a distinguished career that also included key contributions to the HPV vaccine Gardasil from Merck & Co. Inc. (NYSE:MRK), for whom she worked for 12 years. Pfizer said Jansen’s successor would be named after a search had been conducted. 

Bakul Patel, chief digital health officer at FDA, disclosed his resignation from the agency in a LinkedIn post. Patel’s contributions at the agency included working with international regulators to create the term software as a medical device (SaMD), and launching its Digital Health Center of Excellence. Patel was just promoted to chief digital health officer of global strategy and innovation in February. ...